Cushman, MD, professor of physical medicine and rehabilitation at the University of Utah Health
Standard oral formulations achieve only 0.7% bioavailability, limiting blood level increases compared to IV delivery
Funding This work was supported by the National Natural Science Foundation of China (grant no
* Correspondence: Feng Luo, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Currently, Klow Blend is being investigated for potential applications in soft tissue regeneration studies, inflammation signaling research, cellular migration models, and recovery pathways associated with tissue stress or injury